Mechanisms of the TGF-β1/Smad3-signaling pathway in gender differences in alcoholic liver fibrosis
Abstract The TGF-β1/Smad3-signaling pathway and gender differences were investigated in alcoholic liver fibrosis. Mice were divided into female normal, female model, male normal, and male model groups. Liver injury and fibrosis were assessed using histopathology and serology. Western blotting was pe...
| Published in: | Journal of Physiological Sciences |
|---|---|
| Main Authors: | Xiaomin Hong, Sanqiang Li, Renli Luo, Mengli Yang, Junfei Wu, Shuning Chen, Siyu Zhu |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-02-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12576-024-00901-y |
Similar Items
The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment
by: Feilong Chen, et al.
Published: (2025-09-01)
by: Feilong Chen, et al.
Published: (2025-09-01)
Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2022-09-01)
by: Qian Huang, et al.
Published: (2022-09-01)
Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation
by: Zhang Qingwei, et al.
Published: (2024-04-01)
by: Zhang Qingwei, et al.
Published: (2024-04-01)
Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2024-12-01)
by: Qian Huang, et al.
Published: (2024-12-01)
Ellagic Acid Inhibits TGFβ1/Smad-Induced Renal Fibrosis in Diabetic Kidney Injury
by: Ozkan Gorgulu, et al.
Published: (2022-12-01)
by: Ozkan Gorgulu, et al.
Published: (2022-12-01)
Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway
by: Ziqing Yu, et al.
Published: (2024-01-01)
by: Ziqing Yu, et al.
Published: (2024-01-01)
SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis
by: Meng Tu, et al.
Published: (2024-10-01)
by: Meng Tu, et al.
Published: (2024-10-01)
Identification of Tisp40 as an Essential Regulator of Renal Tubulointerstitial Fibrosis via TGF-β/Smads Pathway
by: Cheng-cheng Xiao, et al.
Published: (2017-06-01)
by: Cheng-cheng Xiao, et al.
Published: (2017-06-01)
Differential regulation of TGF-β/Smad signaling in hepatic stallate cells between acute and chronic liver injuries
by: Katsunori eYoshida, et al.
Published: (2012-03-01)
by: Katsunori eYoshida, et al.
Published: (2012-03-01)
The total polyphenolic glycoside extract of Lamiophlomis rotata ameliorates hepatic fibrosis through apoptosis by TGF-β/Smad signaling pathway
by: Guoguo Wan, et al.
Published: (2023-02-01)
by: Guoguo Wan, et al.
Published: (2023-02-01)
CCN5 negatively regulates TGF-β-induced endometriosis associated fibrosis through Wnt/β-catenin signaling via Smad3-dependent mechanism
by: Mian Liu, et al.
Published: (2025-07-01)
by: Mian Liu, et al.
Published: (2025-07-01)
TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
by: Lih-Fhung Hiew, et al.
Published: (2021-06-01)
by: Lih-Fhung Hiew, et al.
Published: (2021-06-01)
Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination
by: Feng Xie, et al.
Published: (2014-10-01)
by: Feng Xie, et al.
Published: (2014-10-01)
Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease
by: Zhi-Hao Zhang, et al.
Published: (2018-09-01)
by: Zhi-Hao Zhang, et al.
Published: (2018-09-01)
UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway
by: Lijie Yang, et al.
Published: (2025-01-01)
by: Lijie Yang, et al.
Published: (2025-01-01)
GNMT inhibits intrauterine adhesion fibrosis through TGF-β1/Smad3 signaling pathway and its mechanism
by: GU Hong, et al.
Published: (2024-09-01)
by: GU Hong, et al.
Published: (2024-09-01)
Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT1 and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition
by: Qun Yu, et al.
Published: (2022-05-01)
by: Qun Yu, et al.
Published: (2022-05-01)
INHBA knockdown inhibits renal fibrosis in mice following ischemia–reperfusion injury by suppressing activation of the TGF-β/Smad signaling pathway
by: Yifei Wang, et al.
Published: (2025-09-01)
by: Yifei Wang, et al.
Published: (2025-09-01)
Preclinical validation of TGFβ inhibitors as a novel therapeutic strategy for post-traumatic heterotopic ossification
by: Jaira Ferreira de Vasconcellos, et al.
Published: (2025-04-01)
by: Jaira Ferreira de Vasconcellos, et al.
Published: (2025-04-01)
SQLE promotes osteosarcoma progression via activating TGFβ/SMAD signaling pathway
by: Qi Song, et al.
Published: (2024-12-01)
by: Qi Song, et al.
Published: (2024-12-01)
An intricate role of Ang II/AT1 in the modulation of monosodium glutamate-induced pulmonary fibrosis by TGF-β/Smad through quercetin
by: Arnab Banerjee, et al.
Published: (2025-07-01)
by: Arnab Banerjee, et al.
Published: (2025-07-01)
Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling
by: Qing Shi, et al.
Published: (2024-04-01)
by: Qing Shi, et al.
Published: (2024-04-01)
Activation of primary hepatic stellate cells and liver fibrosis induced by targeting TGF-β1/Smad signaling in schistosomiasis in mice
by: Ping Huang, et al.
Published: (2022-12-01)
by: Ping Huang, et al.
Published: (2022-12-01)
The Interactivity between TGFβ and BMP Signaling in Organogenesis, Fibrosis, and Cancer
by: Francesco Dituri, et al.
Published: (2019-09-01)
by: Francesco Dituri, et al.
Published: (2019-09-01)
The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis
by: Pramod Mallikarjuna, et al.
Published: (2022-04-01)
by: Pramod Mallikarjuna, et al.
Published: (2022-04-01)
The promotive role of reticulocalbin 3 (RCN3) in the pathogenesis of keloid via TGFβ1/Smad2/Smad7 signaling pathway in vitro
by: Wang HongYu, et al.
Published: (2024-12-01)
by: Wang HongYu, et al.
Published: (2024-12-01)
The Role of the TGF-β Superfamily in Myocardial Infarction
by: Anis Hanna, et al.
Published: (2019-09-01)
by: Anis Hanna, et al.
Published: (2019-09-01)
Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway
by: Xudong Song, et al.
Published: (2022-07-01)
by: Xudong Song, et al.
Published: (2022-07-01)
Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway
by: Chunjun Li, et al.
Published: (2023-02-01)
by: Chunjun Li, et al.
Published: (2023-02-01)
Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure
by: Feifei Zhang, et al.
Published: (2016-06-01)
by: Feifei Zhang, et al.
Published: (2016-06-01)
Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer
by: Xiongqun Peng, et al.
Published: (2023-09-01)
by: Xiongqun Peng, et al.
Published: (2023-09-01)
Advances on TGF-β/Smad signal pathway in hepatic fibrosis
by: Han Daoning, et al.
Published: (2021-09-01)
by: Han Daoning, et al.
Published: (2021-09-01)
Traditional Chinese Medicine targeting the TGF-β/Smad signaling pathway as a potential therapeutic strategy for renal fibrosis
by: Hao Jiao, et al.
Published: (2025-05-01)
by: Hao Jiao, et al.
Published: (2025-05-01)
Environmentally relevant concentration PFNA promotes degradation of SMAD7 to drive progression of ovarian cancer via TGF-β/SMADs signaling pathway
by: Jiamin Zhong, et al.
Published: (2024-10-01)
by: Jiamin Zhong, et al.
Published: (2024-10-01)
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
by: Kelly L. Walton, et al.
Published: (2017-07-01)
by: Kelly L. Walton, et al.
Published: (2017-07-01)
Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway
by: Lu Ding, et al.
Published: (2022-01-01)
by: Lu Ding, et al.
Published: (2022-01-01)
Rebalancing TGF‐β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis
by: Yang Yang, et al.
Published: (2021-07-01)
by: Yang Yang, et al.
Published: (2021-07-01)
OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7
by: Chenchen Geng, et al.
Published: (2025-05-01)
by: Chenchen Geng, et al.
Published: (2025-05-01)
Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin
by: Guang-Yu Lian, et al.
Published: (2021-03-01)
by: Guang-Yu Lian, et al.
Published: (2021-03-01)
Nebivolol ameliorates sepsis-evoked kidney dysfunction by targeting oxidative stress and TGF-β/Smad/p53 pathway
by: Rahma Tharwat Sabra, et al.
Published: (2024-06-01)
by: Rahma Tharwat Sabra, et al.
Published: (2024-06-01)
Similar Items
-
The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment
by: Feilong Chen, et al.
Published: (2025-09-01) -
Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2022-09-01) -
Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation
by: Zhang Qingwei, et al.
Published: (2024-04-01) -
Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2024-12-01) -
Ellagic Acid Inhibits TGFβ1/Smad-Induced Renal Fibrosis in Diabetic Kidney Injury
by: Ozkan Gorgulu, et al.
Published: (2022-12-01)
